In 2021, the market was valued at USD 912.5 million, and it is projected to reach USD 1,841.2 million by 2028, growing at a CAGR of 11.0% during 2022-2028. Key factors driving this growth include: The ...
Despite a solid long-term growth story and strong cash reserves, the high VCYT stock valuation suggests a "hold" rating until ...
Future Market Insights (FMI), a leading authority in market research and consulting, has released an insightful forecast highlighting significant expansion in the global anatomic pathology market.
The United States market has remained flat over the past week but has shown a robust 21% increase over the last year, with earnings projected to grow by 14% annually. In this dynamic environment, ...
The biotech industry thrives on innovation, but conveying complex ideas to diverse audiences requires specialized expertise.
Q4 2024 Earnings Call Transcript February 24, 2025 Veracyte, Inc. beats earnings expectations. Reported EPS is $0.36, ...
Advanced Lateral Flow Conference (ALFC), presented by DCN Dx, is set to take place Oct. 14-15, 2025, in a stunning new location: the Hilton La Jolla Torrey Pines in La Jolla, California. Known for its ...
Welcome to the Veracyte fourth quarter and full year 2024 financial results webcast. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the ...
X AB ("2cureX") hereby publishes the interim report for the second half year of 2024. The interim report is available as an attached document as well as on the company's website ( ...
Veracyte topped Q4 earnings and revenue estimates as testing volume grew. The company is evaluating options for its French unit.
21h
Medical Device Network on MSNBiomerica’s tests for IBD conditions gain CE-marking under EU’s IVDRBiomerica has received CE-marking for its food intolerance tests tailored for ulcerative colitis and Crohn's disease, under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results